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Abstract
Background: We provide a systematic study of the sources of variability in expression profiling
data using 56 RNAs isolated from human muscle biopsies (34 Affymetrix MuscleChip arrays), and
36 murine cell culture and tissue RNAs (42 Affymetrix U74Av2 arrays).
Results: We studied muscle biopsies from 28 human subjects as well as murine myogenic cell
cultures, muscle, and spleens. Human MuscleChip arrays (4,601 probe sets) and murine U74Av2
Affymetrix microarrays were used for expression profiling. RNAs were profiled both singly, and as
mixed groups. Variables studied included tissue heterogeneity, cRNA probe production, patient
diagnosis, and GeneChip hybridizations. We found that the greatest source of variability was often
different regions of the same patient muscle biopsy, reflecting variation in cell type content even in
a relatively homogeneous tissue such as muscle. Inter-patient variation was also very high (SNP
noise). Experimental variation (RNA, cDNA, cRNA, or GeneChip) was minor. Pre-profile mixing
of patient cRNA samples effectively normalized both intra- and inter-patient sources of variation,
while retaining a high degree of specificity of the individual profiles (86% of statistically significant
differences detected by absolute analysis; and 85% by a 4-pairwise comparison survival method).
Conclusions: Using unsupervised cluster analysis and correlation coefficients of 92 RNA samples
on 76 oligonucleotide microarrays, we found that experimental error was not a significant source
of unwanted variability in expression profiling experiments. Major sources of variability were from
use of small tissue biopsies, particularly in humans where there is substantial inter-patient variability
(SNP noise).
Background
Expression profiling is an emerging experimental method
whereby RNA accumulation in cells and tissues can be as-
sayed for many thousands of genes simultaneously in a
single experiment. There are two common experimental
platforms for expression profiling; redundant oligonucle-
otide arrays (Affymetrix GeneChips) [1], and spotted
cDNA microarrays [2–4]. The Affymetrix GeneChips have
the inherent advantages of redundancy, specificity, and
transportability; there are typically 30–40 oligonucleotide
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probes (features) designed against each gene tested by the
array, with paired perfect-match and mismatch probes,
with standardized factory synthesis of arrays [5,6]. The
uniform nature of the arrays permits databasing of indi-
vidual profiles, which facilitates comparison of data gen-
erated by different laboratories.
Expression profiling has led to dramatic advances in un-
derstanding of yeast biology, where homogeneous cul-
tures can be grown and exposed to timed environmental
variables [7–12]. Such studies have led to the rapid assign-
ment of function to a large number of anonymous gene
sequences. Large-scale expression profiling studies of tis-
sues from higher vertebrates are more challenging, due to
the higher complexity of the genome, larger related gene
families, and incomplete genomic resources. Neverthe-
less, DNA microarrays have been successfully applied in
the analysis of aging and caloric restriction [13] and pul-
monary fibrosis [14]. And many publications, particularly
on cancer, have appeared [14–19]. Affymetrix has recently
announced the availability of the U133 GeneChip series
with 33,000 well-characterized human genes mined from
genomic sequence. The nearly complete ascertainment of
genes in the human genome should make expression-pro-
filing studies of human tissues particularly powerful.
However, identification of the sources of experimental
variability, and knowledge of the relative contribution of
variation from each source, is critical for appropriate ex-
perimental design in expression profiling experiments.
Mills and Gordon recently studied the relative contribu-
tion of experimental variability of probe production on
the reproducibility of microarray results using mixed
murine tissue RNA on Affymetrix Mu11K GeneChips [20].
In their study, the same RNA preparation was used as a
template for distinct cDNA/cRNA amplifications and hy-
bridizations. An additional variable studied was the effect
of different laboratories processing the same RNAs. The
authors found relatively poor concordance between du-
plicate arrays, with an average of 12% increase/decrease
calls between the same RNA processed in parallel and hy-
bridized to two Mu11K-A microarrays. The authors con-
cluded that there was substantial experimental variability
in the experimental procedure, necessitating extensive fil-
tering and large numbers of arrays to detect accurate gene
expression changes (LUT: look-up tables) [20]. In our lab-
oratory, we have processed over 1,200 Affymetrix arrays,
and have found significantly higher experimental repro-
ducibility (R2 = 0.979 for new generation U74A version 2
murine arrays or human U95 series, see Result and Dis-
cussion). In addition, a recent publication of a single hu-
man patient, where RNA was prepared from two distinct
breast tumors, and placed on duplicate U95A GeneChips
(four chips total) found a very low degree of experimental
variability between microarrays (R2 = 0.995), and be-
tween the two tumors (R2 = 0.987) [21]. The marked dif-
ferences in experimental variability between laboratories
could be due to different quality control protocols (see
[http://microarray.cnmcresearch.org] ), newer more ro-
bust Affymetrix arrays now available (murine Mu11K ver-
sus U74A version 2 and new generation human U95
series), use of more recent algorithms for data interpreta-
tion, or due to more consistent processing of RNA, cDNA,
and cRNA in the same laboratory.
The previous studies did not systematically address the re-
producibility of GeneChip hybridization (e.g. the same
biotinylated cRNA on two different microarrays). In addi-
tion to lingering questions concerning variability due to
specific experimental procedures, there are other possible
sources of variability that have not yet been investigated,
specifically tissue heterogeneity and inter-individual vari-
ation. The latter two sources of variability are particularly
important in human expression profiling studies. The
study of human tissues often involves the use of tissue bi-
opsies, where a relatively limited region of an organ is
sampled. Tissue heterogeneity and sampling error might
be expected to introduce significant variability in expres-
sion profiles. Second, tissues may derive from individuals
from different ethnic backgrounds; humans are highly
outbred, leading to the potential of significant polymor-
phic noise (herein called "SNP noise") between individu-
als unrelated to the disease or variable under study. SNP
noise also exists between different inbred mouse strains,
and some experiments have normalized this effect by
breeding the same mutation on different strains, and pro-
filing each individually [22]. Knowledge of the relative ef-
fect of each experimental, tissue, and patient variable on
expression profiling results in humans is important, so
that appropriate experimental designs can be employed.
We recently reported the design and production of a high-
ly redundant oligonucleotide microarray for analysis of
human muscle biopsies (Borup et al. submitted). This Mus-
cleChip contains 4,601 probe sets corresponding to 3,369
distinct genes and ESTs expressed in human muscle. Each
probe set contains between 16 to 40 oligonucleotides,
such that the number of specific oligonucleotide probes
on the array was 138,000.
Here, we utilize this MuscleChip to investigate the relative
significance of variables affecting expression profiling
data and interpretation. Specifically, we studied the corre-
lation coefficients of profiles considering the following
variables: 1. variation due to probe production (same
RNA); 2. variation due to the microarray itself (same
cRNA on different GeneChips); 3. tissue heterogeneity
(different regions of the same muscle biopsy); 4. inter-pa-
tient variability (SNP noise); 5. diagnosis (underlying
pathological variable); and 6. patient age.BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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Table 1: Patient data and characteristics of 34 MuscleChip expression profiles.
Patients/ Arrays Individual 
or Mixed
Age 
(years)
Stage of histopathology Scaling Factor % 
Present 
Calls
% Diff 
Calls 
Paired 
samples
Four comparisons > 2-
fold changes relative 
to controls 1a, 1b
1a Ind 5.5 mid 1.08 51 5.6 302
1b 0.9 50
2a Ind 4.5 early stage 1.93 38 3 427
2b 3.28 36
3a Ind 5 early/mid stage 0.53 49 8.6 312
3b 0.97 44
3a-dup Ind 5 early/mid stage 0.46 50 0.8 N/A
3b-dup 0.82 46 2.1
4a Ind 6 mid 0.78 51 18 324
4b 1.02 50
5a Ind 5 early 1.26 51 6.2 453
5b 2.13 40
6a Ind 12 mid 2.72 35 1.5 305
6b 2.46 38
7a Ind 11 mid/moderate 0.79 51 2.6 356
7b 0.9 49
8a Ind 10 mid 1.24 49 1.5 463
8b 1.74 50
9a Ind 11 variable 1.04 50 8.5 266
9b 1.37 46
10a Ind 10 mid/late 0.48 52 1.5 250
10b 0.75 48
6-9mix-1a mix 6 to 9 5 patients biopsies, cRNAs 
mixed
0.82 49 3.2 289
6-9mix-1b mix 1.16 55
5-6mix-1a mix 5 to 6 5 patients biopsies, cRNAs 
mixed
0.67 60 0.5 486
5-6mix-1b mix 1.03 58BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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We have recently reported generation of expression profil-
ing results using mixed patient samples [23]. Our hypoth-
esis was that mixing of RNA samples from multiple
regions of muscle biopsies, and from multiple patients
matched for most variables (disease, age, sex), would ef-
fectively normalize both intra-patient variability (tissue
heterogeneity), and inter-patient variability (SNP noise;
e.g. normal human polymorphic variation unrelated to
the primary defect). Here, we test this hypothesis directly,
and show that sample mixing does indeed result in rela-
tively high sensitivity and specificity for gene expression
changes that would be detected by many individual ex-
pression profiles. Thus, sample mixing appears to be an
appropriate first-pass method to obtain the most signifi-
cant expression changes, while using small numbers of ar-
rays.
Results and discussion
Fifty six (56) different RNA samples were prepared from
different regions of muscle biopsies from 28 individuals
(15 Duchenne muscular dystrophy (DMD) patients, 13
normal controls). The profiles of five of the DMD patients
and the five controls have been previously reported using
the Affymetrix HuFL microarray [23]; however, we re-test-
ed these same samples on the custom MuscleChip (Borup
et al. submitted) for comparison to the other patients here.
All RNAs were converted to double-stranded cDNA, and
then to biotinylated cRNA. The cRNAs were then hybrid-
ized to the MuscleChip either singly, in mixed groups, or
both, as described below. In total, 34 hybridizations were
performed, scanned, and the data statistically analyzed us-
ing Affymetrix Microarray Suite and Excel. Quality control
criteria were as described on our web site ( [http://micro-
array.cnmcresearch.org] , link to "programs in genomic
applications"), and included sufficient cRNA amplifica-
tion, and adequate post-hybridization scaling factors.
Scaling factors (normalization needed to reach a common
target intensity) ranged from 0.46 to 3.28 (Table 1). All
raw image files, processed image files, and difference anal-
yses are posted on a web-queried SQL database interface
to our Affymetrix LIMS Oracle warehouse (see  [http://
microarray.cnmcresearch.org] : link to "programs in ge-
nomic applications", "data", "human").
Among the 4,601 probe sets on the Affymetrix custom
muscle microarray, we found a consistent percentage of
"present" calls for each of the 34 cRNA samples tested
(Duchenne dystrophy, 28 arrays, 48.2% ± 6.1%; controls
6 arrays, 53.3% ± 1.4%). To test for inter-array variability,
two different hybridization solutions were applied to du-
plicate arrays, and correlation coefficients determined. A
high correlation coefficient was found in this analysis,
suggesting that inter-array variability of the MuscleChip
used was a relatively minor variable (Patient 3 a and 3a-
duplicate R2 = 0.96 and percent shared [No Change (NC)]
calls by Microarray Suite software was 99%; Patient 3b
and 3b-duplicate R2 = 0.98 and percent NC was 98%; Ta-
ble 1). The high reproducibility of Affymetrix array results
is consistent with other data in our laboratory, and from
previously published data [6,21,23,24], and shows that
experimental variability associated with hybridization
and scanning of highly redundant oligonucleotide Gene-
Chips is not a major source of experimental variability.
Given the previous report suggesting that the conversion
of RNA to biotinylated cRNA probe was a major source of
variability in murine array experiments [20], we tested a
series of murine RNA from different sources, using the
10-12mix-1a mix 10 to 
12
5 patients biopsies, cRNAs 
mixed
0.82 49 0.4 388
10-12mix-1b mix 1.16 55
control 1a mix 6 to 9 5 normal biopsies, cRNAs 
mixed
0.71 53 1.5 N/A
control 1b mix 0.48 54
control 2a mix 5 to 12 3 normal biopsies, cRNAs 
mixed
0.86 54 0.8 N/A
control 2b mix 0.78 53
control 3a mix 4 to 13 3 normal biopsies, cRNAs 
mixed
0.95 51 1.1 N/A
control 3b mix 0.78 55
Table 1: Patient data and characteristics of 34 MuscleChip expression profiles. (Continued)BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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Figure 1
Unsupervised hierarchical clustering of 42 murine U74Av2 Affymetrix arrays. Unsupervised hierarchical clustering
of 42 murine U74Av2 Affymetrix arrays shows that probe synthesis and hybridization is not a major source of experimental
variability. Expression profiles shown were from three different experimental groups; one using cultured murine myogenic cells
(VSM samples), one using mouse spleens (KNagaraju samples), and one group from mouse skeletal muscle from normal and
mdx mouse strains (FBooth samples). For the KNagaraju samples, the same spleen RNA was split prior to cDNA synthesis to
create duplicate cDNA-cRNA-profile results; these duplicates show a very high correlation coefficient, and close relationship
by Unsupervised clustering (low branches on dendrogram). The VSM cultured samples were each derived from different cul-
ture plates, and the FBooth samples from different murine muscles. The duplicate murine muscle samples are more closely
related (high correlation coefficient) than the parallel cultures (VSM). Additional variables, such as male versus female (KNaga-
raju samples), and time after TSA treatment (VSM samples) are indicated, but are not relevant for this manuscript, and will be
discussed in more detail elsewhere.BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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newer generation U74Av2 GeneChips. One series of sam-
ples was from murine spleens, where spleens from multi-
ple animals for each variable under study were mixed,
RNA isolated, RNA samples split, and duplicate cDNA, cR-
NA, and hybridizations processed in parallel for each RNA
(Fig. 1, "KNagaraju" samples). We also compared RNAs
processed from parallel murine myogenic cell cultures
(Fig. 1, "VSM" samples), where each profile was from a
different cell culture. Finally, we used a series of murine
muscle tissues from normal and dystrophin-deficient
mice, where each profile was from a different series of
complete gastrocnemius muscles (Fig. 1, "FBooth" sam-
ples). The data from these 42 murine U74Av2 profiles
were then analyzed by unsupervised clustering [25] to de-
termine which profiles were most closely related to each
other (Fig. 1). This analysis shows that the different sourc-
es of RNA cluster together, as expected. Importantly, the
same RNA used as a template for two distinct cDNA/cRNA
preparations and hybridizations showed a high correla-
tion coefficient (R2 = 0.99 for five of the six samples, with
average R2 = 0.978) (Fig. 1). The large muscle group pro-
files (FBooth samples) showed excellent correlation, both
with respect to diagnosis; however here there was no sam-
pling error as the entire muscle group was used rather than
isolated biopsies. Finally, the parallel tissue culture exper-
iments (VSM samples) showed greater variability between
duplicates, suggesting that tissue culture conditions may
be more subject to variability than in vivo tissues (Fig. 1).
This murine data shows that variability from different
cDNA-cRNA reactions is very low (R2 = 0.978).
To analyze the impact of intra-patient variability (tissue
heterogeneity), inter-patient variability (polymorphic
noise in outbred populations), and the effect of sample
mixing on the sensitivity of detection of gene expression
differences between patient groups, we conducted a series
of individual and mixed profiling (Table 1). Muscle biop-
sies from five 4–6 yr old DMD patients, and five 10–12 yr
old patients were selected, each biopsy split into two
parts, and RNA isolated independently from each of the
20 biopsy fragments. For these ten DMD patients, the two
different regions of the same biopsy were expression pro-
filed both individually (20 profiles), and also mixed into
four pools where each pool originated from distinct RNA
samples (Table 1). The resulting profiles were also com-
pared to previously reported mixed 6–9 yr old DMD pa-
tient cRNAs, and mixed 6–9 yr old control cRNAs [23], as
mentioned above.
As an initial statistical analysis, we used Affymetrix soft-
ware to define genes that showed expression changes (In-
creased, Decreased or Marginal) in expression levels
between pairs of profiles (difference analyses). This meth-
od of data interpretation showed that some muscle biop-
sies showed very little variance between different regions
of the same biopsy, while other patient biopsies showed
considerable variability (see Fig. 2 for representative scat-
ter graphs). Expressing this variance as a percentage of
"Diff Calls" between the two regions of the same biopsy,
as determined by Affymetrix default algorithms, we found
considerable variability in the similarity of profiles, with
values ranging from 1.5% to 18% of the 4,601 probe sets
studied (4.99% ± 4.94%). This data suggests that tissue
heterogeneity (intra-patient variability) can be a major
source of variation in expression profiling experiments,
even when using relatively large pieces (50 mg) of relative-
ly homogeneous tissues (such as muscle).
The most common strategy for interpreting Affymetrix
microarray data is to use two profile comparisons, with an
arbitrary threshold for "significant fold-change" in expres-
sion levels. Typically, multiple arrays are compared, with
those gene expression changes showing the most consist-
ent fold changes prioritized, although other methods have
been reported [13,22,26,27]. To study inter-patient varia-
bility, we defined the gene expression changes surviving
four pairwise comparisons with mixed control samples, as
we have previously described [23]. Briefly, four compari-
sons were done by Affymetrix software (eg. DMD 1a ver-
sus control 1a; DMD 1a versus control 1b; DMD1b versus
control 1a; DMD1b versus control 1b). The four data sets
were then compared, with only those gene expression
changes that showed >2-fold change in all four compari-
sons (four comparison survival method). The number of
surviving diff calls by this method ranged from 250 to 463
(355 ± 80) (Table 1). Interestingly, those patients showing
considerable variation between different regions of the
same biopsy did not show a corresponding decrease in the
number of gene expression changes surviving the iterative
comparisons to controls (Table 1). This suggests (but does
not prove) the most significant changes might be shared,
independent of tissue variability (see below).
A different statistical method to determine the effect of the
different variables under study is to perform hierarchical
cluster analysis using nearest neighbor statistical methods
[25]. Here, we subjected all profiles to unsupervised clus-
ter analysis, as a means of determining which variables
had the greatest effect (e.g. intra-patient variability [differ-
ent regions of biopsy], versus diagnosis [DMD vs control],
versus inter-patient variability [DMD patients in same age
group], versus age of patient). For this analysis, we used
the fluorescence intensity of each probe set (Average dif-
ference), after data scrubbing to remove genes that
showed expression levels near background ("Absent"
Calls) for all profiles (Fig. 3). This analysis shows that du-
plicate profiles of the same cRNA hybridization solution
are the most highly related (Patient 3 a and duplicate (3a-
d); 3b and duplicate (3b-d)), consistent with the high cor-
relation found by the comparisons using AffymetrixBMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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Figure 2
Different regions of the same tissue specimen can give highly similar or highly discordant expression profiles.
Shown are scatter plots of the expression profiles of two different regions of the same muscle biopsy from patient 6 (Panel A),
and patient 4 (Panel B). Only "present" calls are shown (~2,000 of the 4,600 probe sets studied). An example of one patient
showing very high concordance between two different biopsy regions is shown (panel A), and an example of a second patient
showing very poor correlation between the two biopsy fragments (panel B). The solid lines indicate two-, three-, ten- and
thirty-fold difference thresholds.
18% of Diff Calls
1.5% of Diff Calls  A
BBMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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Microarray Suite software described above. Again, this re-
flects the low amount of combined experimental variabil-
ity intrinsic to the laboratory processing of RNA, cDNA,
cRNA and hybridization.
When comparing two different regions of the same biopsy
[intra-patient variability], we found widely varying re-
sults, depending on the patient studied (Fig. 3). For exam-
ple, some individual patients showed very closely related
profiles that approached the similarity of duplicate arrays
on the same cRNA (Fig. 2; profiles 6a, 6b; 10a, 10b). On
the other hand, some patients showed very distantly relat-
ed profiles for two regions of the same biopsy (Fig. 3; pro-
files 1a, 1b; 4a, 4b; 9a, 9b). Importantly, the variation
caused by intra-patient tissue variation often overshad-
owed all other variables. For example, a profile from
DMD patient 9 (9a) clustered with the normal controls,
rather than with the other DMD patients (Fig. 3). The his-
topathology of this patient was noted as being unusually
variable in severity prior to expression profiling. Also, un-
supervised clustering was unable to group patients of sim-
ilar ages, despite DMD showing a progressive clinical
course. We conclude that intra-patient tissue heterogenei-
ty is a major source of experimental variability in expres-
sion profiling, and must be considered in experimental
design.
The above findings suggested that both intra-patient vari-
ability (tissue heterogeneity) and inter-patient variability
(polymorphic noise) had major effects on the expression
profiles. One method to control for these sources of noise
is to analyze large numbers of profiles, both on multiple
patients, and on multiple regions of tissue from each pa-
tient. This would allow determinations of p values and
statistical significance for a single controlled variable un-
der study (e.g. DMD vs controls). An alternative method
is to experimentally normalize these variables through
mixing of samples from patient groups; such mixing
would be expected to average out both intra- and inter-pa-
tient variation. The expectation is that the most significant
and dramatic gene expression changes would still be iden-
tified, while using many less profiles (and thus a substan-
tial reduction in cost of the analyses).
To test for the relative sensitivity of interpretation of sam-
ple mixing versus individual profiles, we mixed together
the 10 cRNAs for the two different age groups of DMD pa-
tients (samples 1a - 5b; samples 6a - 10b). For this analy-
sis, we also generated expression profiles for two
additional groups of control individuals. One was a sec-
ond set of five normal male biopsies ages 5–12 yrs (con-
trols 2a, 2b), and the third control set was three normal
Figure 3
Unsupervised hierarchical clustering of 24 human
MuscleChip Affymetrix arrays. A dendrogram of nearest
neighbor analysis of 24 MuscleChip expression profiles
shows that intra-patient tissue heterogeneity can be a greater
source of experimental variability than inter-patient or age-
dependent variation. The height of the branch-point of each
tree reflects the extent of relatedness of the different pro-
files. The two profiles for each patient or mixed controls are
from different regions of the same muscle biopsies.
Control (normal) muscles
5-6 years old DMD muscles
10-12 years old DMD muscles
Figure 4
Unsupervised hierarchical clustering of mixed and
individual profiles. Shown is a dendrogram of nearest
neighbor analysis of 34 MuscleChip expression profiles
including both individual and mixed samples. Mixed samples
cluster as very highly related samples, even though different
regions of the component biopsies were used to generate
the duplicates. Importantly, the mixed DMD profiles cluster
more closely with mixed normal controls than with individual
DMD patient profiles. This data suggests that intra-patient
(tissue heterogeneity) and inter-patient (SNP noise) can be
significant sources of experimental variability.
Control (normal) muscles
5-6 years old DMD muscles
10-12 years old DMD muscles
6-9 years old DMD musclesBMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/4
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age-matched female biopsies ages 4–13 yrs (controls 3a,
3b) (Fig. 4). As with the original male control group (con-
trol 1a, 1b), two different regions of each biopsy were
processed independently through the biotinylated cRNA
step, and then equimolar amounts of cRNA mixed for hy-
bridization to the MuscleChip.
All 34 profiles (both individual and mixed samples) were
again analyzed by unsupervised hierarchical clustering
(Fig. 4) [25]. As described above, we scrubbed the profiles
to eliminate all genes showing expression levels consist-
ently at or below background hybridization intensities by
requiring each gene to show a "Present Call" in one or
more of the 34 profiles.
As above, duplicate profiles using the same cRNA hybrid-
ization solution on different arrays, whether mixed or in-
dividual samples, showed very highly correlated results
(very low branch on dendrogram) (Fig. 4; mix 5–6 yrs,
mix 10–12 yrs; patient 3a/3a-d; patient 3b/3b-d). As
above, this indicates that experimental variability from
laboratory procedures or different arrays is a relatively mi-
nor factor in interpretation of results. Mixed samples from
different regions of the same biopsies showed the same, or
only slightly more variation (mixed controls c1, c2, and
c3, mixed DMD 6–9 yrs). This showed that sample mixing
does indeed average out tissue heterogeneity (intra-pa-
tient variability), as well as inter-patient variability. We
noted that all of the controls (both male and female) clus-
tered in the same branch of the dendrogram, while the
four of the six mixed DMD profiles clustered just one level
away from the controls, separately from the other DMD
profiles. This analysis suggests that there is considerable
variability in the progressive tissue pathology induced by
dystrophin deficiency, both within a patient, and between
patients.
To test the sensitivity and specificity of sample mixing ver-
sus individual profiling, we defined differentially ex-
pressed genes using a two group t-test (GeneSpring
[28,29]), comparing all 6 mixed control profiles and the
10 individual 5–6 yr old DMD profiles. Genes were re-
tained that met specific p value thresholds between the
two sets of profiles. In parallel, we compared the two cor-
responding mixed 5–6 yr old DMD profiles to the same 6
mixed control profiles.
Comparison of 10 individual 5–6 yr Duchenne dystrophy
profiles to 6 mixed controls revealed 1,498 genes showing
differential expression with p < 0.05 (Fig. 5). Comparison
of the two mixed Duchenne dystrophy profiles to the 6
mixed controls showed 1,350 genes with p < 0.05 (Fig.
5A). Comparison of the two gene lists showed that 61%
of differentially regulated genes detected by the 10 indi-
vidual profiles were also detected by the two mixed pro-
files. This suggests that the sensitivity and specificity of
using mixed samples is approximately half that of individ-
ual profiles. However, there was a rapid shift in specificity
and sensitivity as stringency of the analysis was increased.
Raising the statistical threshold to p < 0.0001 for individ-
ual profiles, while keeping the threshold for mixed pro-
files at p < 0.05 as required by the small number of data
points (Fig. 5B), resulted in a sensitivity of 86% for mixed
samples (351 of 408 genes p < 0.0001 detected). In con-
clusion, mixing detected about two thirds of statistically
significant changes (p < 0.05). Mixing was a relatively sen-
sitive method of detecting the most highly significant
changes (p < 0.0001) (86% of changes detected), however
it was not very specific; as many as one third of gene ex-
Figure 5
Comparison of individual profiles to mixed profiles
by t-test statistics. Shown in green are differentially
expressed genes for 2 mixed DMD 5–6 y profiles versus 6
mixed controls. Shown in red are differentially expressed
genes for 10 individual DMD 5–6 y profiles and 6 mixed con-
trols. P-value thresholds used to generate gene lists are indi-
cated. The p-value for mixed profiles is held at p < 0.05, as
the low sample number (2 versus 2) precludes obtaining
more significant values. This analysis suggests that the use of
t-test statistics for small number of mixed samples is rela-
tively sensitive, but not highly specific.
585 913 437
39% 61%
32%
14%
74%
86%
57 351 999
P < 0.0001
P < 0.05
68%
Individual Mixed (p<0.05)
Individual Mixed (p<0.05)
26%
A
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pression changes showing p < 0.05 in mixed samples were
not confirmed by individual profiles.
Use of t-test measurements is expected to contain signifi-
cant amounts of noise, due to the very large number of
comparisons involved in array studies; a value of p = 0.05
means that as many as 5% of gene expression changes are
expected to be identified by "chance", and thereby not re-
flect true differences between samples. We have previous-
ly reported a very simple, yet potentially more stringent
method for data analysis of small numbers of expression
profiles, using duplicate profiles for control and experi-
mental samples, and then identifying those genes that
show consistent changes >2-fold in the four possible pair-
wise data comparisons (four comparison survival meth-
od) [23]. A similar pair-wise comparison method, using a
less stringent average fold-change analysis, was recently
reported for muscle from aging and calorie-restricted
mouse muscle [13].
To investigate the validity of this approach we compared
the sensitivity and specificity of t-test detection of expres-
sion changes versus the four-pairwise survival method.
Two sample t-test of the 10 individual Duchenne dystro-
phy profiles compared to the 6 mixed control profiles re-
vealed 1,498 genes showing p < 0.05 as above. In parallel,
the mixed DMD duplicate profiles were compared to a
single pair of mixed control sample profiles (c1a, c1b), us-
ing the pairwise comparison survival method [23]. Briefly,
four comparisons were done (DMD 1a versus control 1a;
DMD1b versus control 1a; DMD 1a versus control 1b;
DMD1b versus control 1b), and only those genes retained
which showed >2-fold change in all four comparisons.
This method was indeed considerably more specific in
identifying significant (p < 0.05) gene expression changes
(Fig. 6A) with 85% of gene expression changes in the
mixed profiles verified by individual profiles (p < 0.05).
The sensitivity of this method depended on the p-value
threshold for the individual profiles, but only reached a
maximum of 49% sensitivity at p < 0.0001 (Fig. 6B).
The results above suggested that analysis of mixed sam-
ples using t-test methods was relatively sensitive but non-
specific, while analysis of the same mixed profiles by 2-
fold survival method was relatively specific but insensi-
tive. To confirm this conclusion, we directly compared the
sensitivity and specificity of the four pairwise comparison
method to more standard t-test methods (Fig. 7A). We
found that the pairwise survival method was indeed high-
ly specific, with 97% of changes identified by this method
also detected by t-test. However, as predicted, it was not
very sensitive, with only 30% of the expression changes
with p < 0.05 identified by t-test being detected by the
pairwise survival method. Comparison of all three analy-
sis methods showed that many (349) genes expression
changes were detected by all three methods (Fig. 7B).
Conclusions
Microarray data analyses have been criticized as being
"quite elusive about measurement reproducibility" [30].
This is largely the consequence of the large number of un-
controlled or unknown variables, and the prohibitive cost
of isolating and investigating each variable. Here, we re-
port the systematic isolation and study of most variables
in microarray experiments using Affymetrix oligonucle-
otide arrays and human tissue biopsies. We found that all
sources of experimental variability were quite minor
(microarray R2 = 0.98–0.99; probe synthesis + microarray
R2 = 0.98–0.99). On the other hand, tissue heterogeneity
Figure 6
Use of >2-fold survival method provides relatively
specific, but insensitive detection of significant gene
changes. Shown in green is a representation of number of
genes surviving four pair-wise comparisons to two mixed
control profiles, with retention of only those genes showing
fold changes > 2-fold in the four pair-wise comparisons.
Shown in red are differentially expressed genes for 10 indi-
vidual DMD 5–6 y profiles versus 6 mixed controls at the
indicated p-value thresholds. This fold-change survival
method shows good specificity at p < 0.05 for individual pro-
files (85%), however it is relatively insensitive.
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(intra-patient variation; Average R2 for 10 patients = 0.92
[0.85 to 0.98]), and differences between individual pa-
tients (SNP noise; Average R2 = 0.76 [0.42 to 0.93]) were
major sources of variability in expression profiling. Thus,
tissue heterogeneity and SNP noise have a high potential
to obscure sought after condition-specific gene expression
changes, particularly in humans, where tissue samples can
be limiting (sampling error), and inter-individual varia-
tion often is very large. We have shown that mixing of pa-
tient samples effectively normalizes much of the intra-
and inter-patient noise, while still identifying the majority
of the most significant gene expression changes that
would have been detected by larger numbers of individual
patient profiles. Our results suggest that stringent yet ro-
bust data can be generated by mixing a small number of
individuals with a defined condition (n = 5), preferably
using different regions of tissue for duplicate arrays. Con-
trols should be similarly processed. The resulting four ar-
rays (2 controls, 2 experimental datasets) should then be
subjected to the >2-fold survival method, as previously
described [23]. This will yield a stringent set of expression
changes that are likely to be verified by larger studies with
individual arrays, but at low cost as only four arrays are
employed. The preliminary data from just four mixed pro-
files (two experimental and two control) can then be used
to generate functional clusters and pathophysiological
models. These preliminary models can then direct more
hypothesis-driven experiments, or more extensive expres-
sion profiling studies.
Materials and methods
Expression profiling
Human muscle biopsy samples were diagnostic speci-
mens flash-frozen immediately after surgery in isopentane
cooled in liquid nitrogen, with storage in small, airtight,
humidified tubes at -80°C until RNA isolation. Duchenne
muscular dystrophy patient samples were all shown to
have complete lack of dystrophin by immunostaining
and/or immunoblot analysis, and were shown to have ex-
cellent morphology and preservation of tissue. Controls
included groups of males and female (age described in
text) that showed no histopathological abnormality, nor-
mal dystrophy proteins, and normal serum creatine ki-
nase levels. Biopsy sizes ranged from 50 mg to 2 grams,
with approximately 20–30 mg used for RNA isolation
(~10–15 micrograms of total RNA). As described in the
text, all biopsies had two different regions of the same bi-
opsy expression profiled separately.
Details concerning the murine profiles will be published
elsewhere. In this report, we used the murine profiles sim-
ply to test the sources of variation during sample prepara-
tion prior to hybridization to oligonucleotides.
RNA isolation (Trizol, Gibco BRL), RNA purification
(RNAeasy, Qiagen), cDNA synthesis and biotinylated
cRNA were all done as per standard protocols provided by
Affymetrix Inc. Quality control methods are described on
our web site ( [http://microarray.cnmcresearch.org/
pga.htm] ), with cRNA amplifications of between 5- and
13-fold for each of the samples. Ten micrograms of gel-
verified fragmented biotinylated cRNA were hybridized to
each MuscleChip or U74A v2 array, and scanning done af-
ter biotin/avidin/phycoerythrin amplification. Details on
the specific patients studied, and details for each Gene-
Chip (scaling factors, number of present calls, percentage
difference calls between each duplicate sample, number
Figure 7
Direct comparison of t-test and four pairwise survival
methods. Shown in green is list of 417 differentially
expressed genes surviving four pair-wise comparisons to
mixed control. Shown in red are differentially expressed
genes for 2 mixed DMD 5–6 y profiles versus 6 mixed con-
trols showing p < 0.05 by t-test. (Panel A) This analysis
shows the survival method to be considerably more stringent
than t-test. Most gene expression changes detected by the
mixed sample survival method are included in changes from
t-test analysis (both mixed and individual profiles). Panel B is
the compilation of previous figures, showing that > 2-fold
survival method using only four mixed profiles (two DMD,
two control) is highly specific but likely insensitive compared
to t-test methods
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of difference calls surviving four pair-wise comparisons of
duplicate chips) is provided (Table 1). All profiling data
presented here is available on our web site ( [http://micro-
array.CNMCResearch.org] ; data link), as image (.dat), ab-
solute analysis (.chp), and ASCII text conversions of .chp
(.txt) for each individual profile (see  [http://microar-
ray.cnmcresearch.org/pga.htm]  for file descriptions and
use).
Bio-informatic methods
Absolute analysis (average difference determinations for
each probe set) was done using Affymetrix default param-
eters. As described in the text, data was analyzed using a
variety of methods, including unsupervised nearest-neigh-
bor hierarchical clustering analyses (GeneSpring [28,29]
[Silicon Genetics], and Cluster [25] [Stanford Universi-
ty]), t-test (GeneSpring) and four-comparison survival
method [23]. The Cluster and Tree View software were
download from  [http://rana.lbl.gov]  and installed on an
NT workstation.
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